Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005; 105: 948–958.

    Article  CAS  PubMed  Google Scholar 

  2. Busch K, Borkhardt A, Wossmann W, Reiter A, Harbott J . Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. Haematologica 2004; 89: 818–825.

    CAS  PubMed  Google Scholar 

  3. Mussolin L, Basso K, Pillon M, d'Amore ES, Lombardi A, Luzzatto L et al. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32). Leukemia 2003; 17: 585–589.

    Article  CAS  PubMed  Google Scholar 

  4. Dworzak MN, Fritsch G, Fleischer C, Printz D, Fröschl G, Buchinger P et al. Comparative phenotype mapping of normal vs malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations. Exp Hematol 1998; 26: 305–313.

    CAS  PubMed  Google Scholar 

  5. Dworzak MN, Froschl G, Printz D, Mann G, Pötschger U, Mühlegger N et al. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood 2002; 99: 1952–1958.

    Article  CAS  PubMed  Google Scholar 

  6. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419–2430.

    Article  CAS  PubMed  Google Scholar 

  7. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 2431–2442.

    Article  CAS  PubMed  Google Scholar 

  8. Attarbaschi A, Mann G, Dworzak M, Trebo M, Urban C, Fink FM et al. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria – therapy results between 1986 and 2000. Wien Klin Wochenschr 2002; 114: 978–986.

    CAS  PubMed  Google Scholar 

  9. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods 2004; 295: 67–78.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Attarbaschi, A., Mann, G., Schumich, A. et al. CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia. Leukemia 21, 1110–1113 (2007). https://doi.org/10.1038/sj.leu.2404608

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404608

This article is cited by

Search

Quick links